1.
Shahid Ullah, Alex Tonks, AMA, Hedib Alkoumi H Alrawili, Asifullah Khan, Ahmad Salem Alanazi, et al. STRUCTURE-BASED VIRTUAL SCREENING STUDY OF FDA‑APPROVED DRUGS TO INHIBIT TP53 72 ARG/PRO VARIANT IDENTIFIED IN ACUTE LYMPHOCYTIC PATIENT VIA WHOLE EXOME SEQUENCING. J Popl Ther Clin Pharmacol [Internet]. 2024 Mar. 25 [cited 2025 Oct. 11];31(3):2304-415. Available from: https://jptcp.com/index.php/jptcp/article/view/5046